ACTINIUM PHARMACEUTICALS, INC.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2009 | — | — | $2.1K |
| Jun 2010 | — | — | $35.1K |
| Sep 2010 | — | — | $150 |
| Dec 2010 | $94.8K | $150 | $196.1K |
| Jun 2011 | $78.3K | $150 | $150 |
| Sep 2011 | $81.8K | $150 | $150 |
| Dec 2011 | $84.5K | $6.2M | $5.7M |
| Mar 2012 | $94.1K | $150 | $150 |
| Jun 2012 | $100.4K | $142 | $4.5M |
| Sep 2012 | $104.0K | $0 | $2.6M |
| Dec 2012 | $4.6M | $5.8M | $5.6M |
| Mar 2013 | $2.8M | $3.4M | $3.2M |
| Jun 2013 | $3.8M | $5.7M | $5.7M |
| Sep 2013 | $3.4M | $4.0M | $4.0M |
| Dec 2013 | $7.3M | $5.8M | $5.5M |
| Mar 2014 | $20.0M | $6.6M | $5.9M |
| Jun 2014 | $11.1M | $15.4M | $14.7M |
| Sep 2014 | $10.2M | $12.6M | $11.8M |
| Dec 2014 | $9.5M | $7.6M | $6.7M |
| Mar 2015 | $3.6M | $20.1M | $19.3M |
| Jun 2015 | $3.1M | $26.3M | $26.0M |
| Sep 2015 | $2.2M | $25.0M | $24.8M |
| Dec 2015 | $4.6M | $26.6M | $25.6M |
| Mar 2016 | $3.3M | $23.3M | $22.2M |
| Jun 2016 | $2.5M | $21.6M | $22.2M |
| Sep 2016 | $3.0M | $17.3M | $15.5M |
| Dec 2016 | $4.5M | $22.5M | $20.5M |
| Mar 2017 | $5.4M | $18.2M | $17.1M |
| Jun 2017 | $4.1M | $13.0M | $11.5M |
| Sep 2017 | $3.5M | $21.7M | $20.5M |
| Dec 2017 | $4.7M | $18.3M | $17.4M |
| Mar 2018 | $6.4M | $28.1M | $26.8M |
| Jun 2018 | $5.3M | $22.6M | $21.5M |
| Sep 2018 | $4.1M | $15.7M | $14.8M |
| Dec 2018 | $6.1M | $14.9M | $13.7M |
| Mar 2019 | $6.9M | $12.2M | $9.9M |
| Jun 2019 | $6.1M | $21.8M | $19.5M |
| Sep 2019 | $6.4M | $16.3M | $14.3M |
| Dec 2019 | $6.0M | $11.7M | $9.3M |
| Mar 2020 | $5.3M | $8.4M | $5.9M |
| Jun 2020 | $5.2M | $56.0M | $53.5M |
| Sep 2020 | $5.1M | $50.5M | $48.2M |
| Dec 2020 | $5.1M | $66.4M | $63.6M |
| Mar 2021 | $4.4M | $75.1M | $72.3M |
| Jun 2021 | $4.0M | $84.5M | $81.9M |
| Sep 2021 | $4.2M | $84.5M | $82.0M |
| Dec 2021 | $6.8M | $80.4M | $77.8M |
| Mar 2022 | $5.7M | $74.6M | $72.0M |
| Jun 2022 | $43.6M | $121.8M | $116.3M |
| Sep 2022 | $45.6M | $116.8M | $111.8M |
| Dec 2022 | $47.7M | $114.2M | $108.9M |
| Mar 2023 | $44.8M | $102.0M | $94.5M |
| Jun 2023 | $46.0M | $99.1M | $91.3M |
| Sep 2023 | $45.4M | $88.9M | $83.0M |
| Dec 2023 | $45.1M | $81.4M | $76.7M |
| Mar 2024 | $44.5M | $88.4M | $84.1M |
| Jun 2024 | $46.0M | $89.9M | $86.0M |
| Sep 2024 | $43.9M | $82.1M | $78.7M |
| Dec 2024 | $44.1M | $76.9M | $72.9M |
| Mar 2025 | $43.0M | $68.6M | $65.3M |
| Jun 2025 | $44.0M | $63.0M | $59.9M |
| Sep 2025 | $42.4M | $56.2M | $53.4M |
| Dec 2025 | $43.9M | $51.8M | $48.0M |
| Mar 2026 | $43.1M | $45.4M | $42.1M |
| Jun 2026 | $9.9M | $40.2M | $36.5M |